The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


Published online July 22, 2009
The Journal of Immunology, 2009, 183, 2718 -2728
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0900849

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jimmunol.0900849v1
183/4/2718    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Zhang, H.
Right arrow Articles by Bokoch, G. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, H.
Right arrow Articles by Bokoch, G. M.

Human Neutrophils Coordinate Chemotaxis by Differential Activation of Rac1 and Rac21

Hui Zhang*, Chunxiang Sun{dagger}, Michael Glogauer{dagger} and Gary M. Bokoch2,*

* Department of Immunology and Microbial Science and Department of Cell Biology, Scripps Research Institute, La Jolla, CA 92037; and {dagger} Canadian Institutes for Health Research Group in Matrix Dynamics and Dental Research Institute, University of Toronto, Faculty of Dentistry, Toronto, Ontario, Canada

Rac1 and Rac2, members of the small Rho GTPase family, play essential roles in coordinating directional migration and superoxide production during neutrophil responses to chemoattractants. Although earlier studies in Rac1 and Rac2 knockout mice have demonstrated unique roles for each Rac isoform in chemotaxis and NADPH oxidase activation, it is still unclear how human neutrophils use Rac1 and Rac2 to achieve their immunological responses to foreign agent stimulation. In the current study, we used TAT dominant-negative Rac1-T17N and Rac2-T17N fusion proteins to acutely alter the activity of Rac1 and Rac2 individually in human neutrophils. We demonstrate distinct activation kinetics and different roles for Rac1 and Rac2 in response to low vs high concentrations of fMLP. These observations were verified using neutrophils from mice in which Rac1 or Rac2 was genetically absent. Based on these results, we propose a model to explain how human neutrophils kill invading microbes while limiting oxidative damage to the adjacent surrounding healthy tissue through the differential activation of Rac1 and Rac2 in response to different concentrations of chemoattractant.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Grant GM39434 from the National Institutes of Health (to G.M.B.) and a Canadian Institutes of Health Research operating grant (to M.G.).

2 Address correspondence and reprint requests to Dr. Gary M. Bokoch, Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037-1092.

3 Abbreviations used in this paper: ROS, reactive oxygen species; DAPI, 4',6-diamidino-2-phenylindole; DIAS, Dynamic Image Analysis System; DIC, differential interference contrast; GEF, guanine nucleotide exchange factor.

4 The online version of this article contains supplemental material.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.